Back
HFA Premium Access

Primary results of TITRATE-HF: 1-year continuous GRMT implementation, prognosis, and LVEF improvement in de novo heart failure with reduced ejection fraction

Session: Registries and clinical trials: new onset and chronic heart failure
Topic: Pharmacotherapy
Speaker: Professor J. Brugts (Rotterdam, NL)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Jasper Brugts

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
15 presentations
2 followers

6 more presentations in this session

Discussant panel

Access
Like
Thumbnail

Sudden cardiac arrest in patients with newly diagnosed NICM or MI/CAD - nationwide analysis of >19.000 patients with a WCD

Speaker: Professor J. Bauersachs (Hannover, DE)

Access
Slides
Video
Like
Thumbnail

Digoxin lowers pulmonary artery pressures and heart rate in patients with heart failure and reduced ejection fraction

Speaker: Professor J. Lindenfeld (Nashville, US)

Access
Slides
Video
Like
Thumbnail

Increased perirenal adipose tissue thickness is associated with autonomic dysfunction and reduced CGRP in patients with HFpEF: a prospective observational study

Speaker: Doctor O. Polat (Afyonkarahisar, TR)

Access
Slides
Video
Like
Thumbnail

Impact of M-TEER on health status in patients with moderate-to-severe functional mitral regurgitation and heart failure: results from RESHAPE-HF2

Speaker: Professor J. Butler (Dallas, US)

Access
Slides
Video
Like
Thumbnail

Access the full session

Registries and clinical trials: new onset and chronic heart failure

Speakers: Professor J. Brugts, Professor J. Bauersachs, Professor J. Lindenfeld, Doctor O. Polat, Professor J. Butler
Access
Video
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources